Lung Cancers Withdrawn Phase 2 Trials for Cetuximab (DB00002)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00998101Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With ChemotherapyTreatment